RSS

Amgen

The US FDA has granted accelerated approval to Amgen’s Blincyto (blinatumomab) to treat adults and children with B-cell precursor acute lymphoblastic leukaemia who are in remission but still have minimal residual disease (MRD) more

News

Amgen and Allergan have received a positive opinion from the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) for the marketing authorisation of ABP 980, a biosimilar to Herceptin (trastuzumab). more

News

Here we count down the top five tweets from @EPM_magazine that have gained the most impressions this week, taken from Twitter analytics. more

News

Innovative molecular diagnostics company, Biocartis Group, and biotechnology company, Amgen, have signed a new companion diagnostic (CDx) development agreement for a novel oncology compound. more

News

Molecular diagnostics company, Biocartis, has signed a companion diagnostic (CDx) development agreement with biotechnology company, Amgen, for the Idylla RAS biomarker tests. more

News

GE Healthcare has opened its first European 3D printing and design centre in Uppsala, Sweden, which will use technologies to speed up the launch of new products for healthcare. more

News

Here we count down the top five tweets from @EPM_magazine that have gained the most impressions this week, taken from Twitter analytics. more

News

The US Food and Drug Administration (FDA) has approved Mvasi (bevacizumab-awwb) as a biosimilar to the cancer treatment Avastin (bevacizumab). This represents the first biosimilar approved by the regulatory body for cancer treatment. more

News

An expensive cholesterol drug, evolocumab, which is prescribed on the NHS, is claimed to do nothing to prevent fatal heart attacks and strokes and a coalition of doctors have called for it to be withdrawn from use. more

News

Sanofi has filed for a pre-merger notification regarding its intention to acquire Medivation, suggesting an acquisition could be back on the cards more

News

A US district court jury have ruled that the asserted claims of two Amgen patents for antibodies targeting PCSK9 are valid, yet Sanofi and Regeneron Pharmaceuticals have announced that they disagree with the verdict more

News

Amgen has invested £53.8m ($75m) in Unilife Corperation as part of a joint agreement to produce wearable injectors more

News